Ingersoll-Rand Inc’s recently made public that its insider Reynal Vicente unloaded Company’s shares for reported $3.21 million on May 20 ’25. In the deal valued at $83.03 per share,38,657 shares were sold. As a result of this transaction, Reynal Vicente now holds 193,186 shares worth roughly $16.12 million.
Then, Reynal Vicente bought 38,657 shares, generating $3,209,772 in total proceeds.
Before that, Hepding Elizabeth Meloy sold 3,500 shares. Ingersoll-Rand Inc shares valued at $293,230 were divested by the insider at a price of $83.78 per share. As a result of the transaction, Hepding Elizabeth Meloy now holds 10,986 shares, worth roughly $0.92 million.
Stifel downgraded its Ingersoll-Rand Inc [IR] rating to a Hold from a a Buy in a research note published on November 18, 2024; the price target was decreased to $107 from $112. Morgan Stanley began covering IR with “an Equal-weight” recommendation on September 06, 2024.
Price Performance Review of IR
On Monday, Ingersoll-Rand Inc [NYSE:IR] saw its stock jump 0.41% to $83.46. Over the last five days, the stock has gained 2.96%. Ingersoll-Rand Inc shares have fallen nearly -7.74% since the year began. Nevertheless, the stocks have fallen -6.99% over the past one year. While a 52-week high of $106.03 was reached on 01/31/25, a 52-week low of $65.61 was recorded on 04/08/25. SMA at 50 days reached $77.79, while 200 days put it at $89.54.
Levels Of Support And Resistance For IR Stock
The 24-hour chart illustrates a support level at 83.12, which if violated will result in even more drops to 82.78. On the upside, there is a resistance level at 83.90. A further resistance level may holdings at 84.34. The Relative Strength Index (RSI) on the 14-day chart is 61.09, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.87, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 11.89%. Stochastics %K at 73.93% indicates the stock is a holding.
The most recent change occurred on March 12, 2024 when Exane BNP Paribas began covering the stock and recommended ‘”a Neutral”‘ rating along with a $92 price target.
